Qube Research & Technologies (QRT)’s Epizyme, Inc EPZM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-74,695	Closed	-$110K	–	3268
2022 Q2	$110K	Buy	+74,695	New	+$54.9K	﹤0.01%	1914
2022 Q1	–	Sell	-293,126	Closed	-$733K	–	3255
2021 Q4	$733K	Buy	+293,126	New	+$1.15M	0.01%	1364
2021 Q1	–	Sell	-17,444	Closed	-$189K	–	2575
2020 Q4	$189K	Buy	+17,444	New	+$215K	﹤0.01%	1548
2020 Q2	–	Sell	-21,186	Closed	-$329K	–	2086
2020 Q1	$329K	Buy	+21,186	New	+$455K	0.01%	704

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EPZM Position: Q3 2022 in Review

Qube Research & Technologies (QRT) sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 74,695 shares — an estimated $110K sold.

Qube Research & Technologies (QRT) first reported a position in EPZM in Q1 2020 and held it in 4 quarters. The position peaked at $733K in Q4 2021. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Qube Research & Technologies (QRT) reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 74,695 Epizyme, Inc shares in Q3 2022, an estimated $110K.
Qube Research & Technologies (QRT) first reported a position in Epizyme, Inc in Q1 2020 and held it in 4 quarters.
Qube Research & Technologies (QRT)'s Epizyme, Inc position peaked at $733K in Q4 2021.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2022, filed 14 Nov 2022.